No image available

Eric Dunbar

Associate

Eric is an associate in the Intellectual Property Transactions Group.

Prior to joining the firm, Eric was an associate at an intellectual property, antitrust and corporate law boutique primarily handling intellectual property counseling matters, including intellectual property litigation, for pharmaceutical, medical device and technology companies.

Experience

Representative matters

Intercontinental Exchange, Inc. in its pending acquisition of Black Knight, Inc., a deal valued at approximately $13 billion.

Anglo American in its ongoing combination of First Mode with Anglo American's nuGen Zero Emissions Haulage Solution.

SAP SE in its pending sale of SAP Litmos to Francisco Partners.

A prominent media and broadcasting company in connection with partnerships for the creation, distribution and exploitation of digital content.

Published Work

  • E. Dunbar and C. Landmon, IP and Collaboration, 41 Pharmaceutical Executive, 21-22 (Mar. 11, 2021)
  • E. Dunbar and C. Landmon, Insights on the MODERN Labeling Act, Axinn FDA Update (Nov. 20, 2020
  • E. Dunbar and J. Harris, Prosecution Counsel Beware: Statutory Bars and Inequitable Conduct, Axinn IP Update Mar. 19, 2020)
  • E. Dunbar, et al., 3 Strategies to Manage Case Scope in ANDA Patent Litigation, Law360 (Dec. 10, 2019)

Qualifications

Admissions

Attorney-at-Law, New York

Courts

United States District Court for the Southern District of New York

United States District Court for the Eastern District of New York

Academic

Boston University School of Law J.D.

University of Chicago B.A., Biological Science, Public Policy

Disclaimer
A&O Shearman was formed on May 1, 2024 by the combination of Shearman & Sterling LLP and Allen & Overy LLP and their respective affiliates (the legacy firms). Any matters referred to above may include matters undertaken by one or more of the legacy firms rather than A&O Shearman.